Ticker Attention Investors: Beware of fraudulent Calls, SMS, Emails, WhatsApp & Telegram messages assuring high returns and / or enticing you to invest money in the name of Aditya Birla Money by installing fake App from spurious links. You can download our Elevate App only from Google Play Store or Apple App Store or login to Elevate Web portal. Click Here to know more.

Aditya Birla Money Limited

Aditya Birla Money Limited

Medicamen Biotech Ltd

Symbol : MEDICAMEQ | BSE Code : 531146 | Sector : PHARMACEUTICALS - INDIAN - FORMULATIONS

405.00-1.40 (-0.34%)
04-Jul-2025 | 12:24
Loading

Market Cap (₹ Cr.)

551.19
Today’s High / Low
411.55
404.95
52 Week High / Low
630.00
375.05
OVERVIEW
  • Open
  • 410.00
  • Prev. Close
  • 406.40
  • High
  • 411.55
  • Low
  • 404.95
  • Market Cap (₹ Cr.)
  • 551.19
  • 52 Week High
  • 630.00
  • 52 Week Low
  • 375.05
  • Traded Volume (Lacs)
  • 11,110
  • Traded Value (Cr)
  • Dividend Yield
  • 0.23
  • Face Value
  • 10.00
  • EPS
  • 6.97
  • P/E
  • 58.41
  • Beta (1 year)
  • 1.02
LAST 5 DAYS

1 YEAR RETURN - UNDERPERFORMED THE SENSEX BY 24.39%

  • 04/07/2025 BSE
    2.60(0.64)
    Close Price: ₹ 407.10
    Volume: 2,388.00

    03-Jul-2025
  • 04/07/2025 BSE
    -9.85(-2.38)
    Close Price: ₹ 404.50
    Volume: 3,766.00

    02-Jul-2025
  • 04/07/2025 BSE
    -2.20(-0.53)
    Close Price: ₹ 414.35
    Volume: 1,316.00

    01-Jul-2025
  • 04/07/2025 BSE
    1.00(0.24)
    Close Price: ₹ 416.55
    Volume: 1,182.00

    30-Jun-2025
  • 04/07/2025 BSE
    -8.45(-1.99)
    Close Price: ₹ 415.55
    Volume: 1,393.00

    27-Jun-2025

1 YEAR RETURN - UNDERPERFORMED THE SENSEX BY 24.39%

  • Stock Absolute
  • -3.99
  • -7.92
  • -20.32
  • -38.34
  • 38.63
  • Returns
  • 1W
  • 1M
  • 1Y
  • 3Y
  • 5Y
  • Sensex Absolute
  • -0.62
  • 3.10
  • 4.07
  • 56.36
  • 131.08
NEWS

Medicamen Biotech Ltd - Medicamen Biotech Limited - Trading Window

01-Jul-2025

Medicamen Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

01
Jul

Medicamen Biotech Ltd - Medicamen Biotech Limited - Trading Window



30
Jun

Medicamen Biotech Ltd - Medicamen Biotech Limited - Trading Window



03
Jun

Medicamen Biotech rallies after securing USFDA approval for Bortezomib injection



FINANCIAL DATA

In Cr.

Mar 2024Mar 2023Mar 2022
SOURCES OF FUNDS :   
Share Capital 12.7112.6512.22
Reserves Total 196.49180.02135.82
Equity Share Warrants0.000.000.00
Equity Application Money0.001.130.00
Read More
Mar 2024Mar 2023Mar 2022
INCOME :   
Sales Turnover 172.39137.88115.45
Excise Duty0.000.000.00
Net Sales172.39137.88115.45
Other Income 2.302.461.72
Read More
ParticularsMar 2025Dec 2024Sep 2024
Gross Sales 26.0041.1442.84
Excise Duty 000
Net Sales 26.0041.1442.84
Other Operating Income 000
Other Income  5.220.140.29
Read More
Category No. Of Shares Percentage (%)
Total Foreign 2387714 17.61
Total Institutions 87921 0.65
Total Govt Holding 7000 0.05
Total Non Promoter Corporate Holding 327712 2.42
Total Promoters 5487095 40.46
Total Public & others 5,265,373.00 38.83
Total 100.00 100.00
Read More
CORPORATE ACTIONS
Record Date Ex-Bonus Date Ratio
nodata
No Data Available!!!
Read More
Record Date Split Date Face Value Before Face Value After
nodata
No Data Available!!!
Read More
Read More
ANNOUNCEMENT DATE EX DIVIDEND DATE DIVIDEND (%) DIVIDEND TYPE
29-05-2024 19-09-2024 10 Final
29-05-2023 20-09-2023 10 Final
25-05-2022 19-09-2022 10 Final
28-06-2021 16-09-2021 10 Final
30-06-2020 17-09-2020 5 Final
PREMIUM (₹) RATIO RECORD DATE EX RIGHTS DATE
nodata
No Data Available!!!
Read More
Read More
FROM DATE EX TO DATE AGENDA
02-06-2025 NA Trading members of the Exchang...
30-05-2025 NA Medicamen Biotech Ltd-has info...
24-04-2025 NA We wish to inform you that the...
31-03-2025 NA Financial Results year ended o...
26-03-2025 NA Announcement under Regulation ...
COMPANY INFO

A diversified enterprise, Medicamen Biotech Limited (MBL) is a research-led pharmaceutical company involved in developing, manufacturing and marketing of finished dosage formulations for domestic as well as international markets. The Company has presence in 40+ countries. Its offerings include Finished Dosage Forms (FDF's) to African countries.

In India, MBL is among the leading companies in oncology segment with its own sales force and a branding team that has helped garner a strong foothold in the domestic market. MBL has three pharma formulation facilities including two in Haridwar (Uttarakhand), one in Bhiwadi (Rajasthan). The Company manufactures products across various therapeutic categories including Pain Management, Cough & Cold, Cardiovascular & Central Nervous System, Anti-Diabetic, Gastrointestinal, Anti-Allergic among others.

The Bhiwadi unit has ultra modern production facilities incorporating latest state of the art technology with a combination of technically qualified personnel and hardworking workforce. In Haridwar unit, the company manufactures Non-Betalactum preparations including tablets, capsules, oral liquids and ointments & creams.

Medicamen Biotech Limited was incorporated in December, 1993 and started their operation as distributor and manufacturer of medicines on loan license basis. The distribution activities were spread manifold over a wide market extending beyond the domestic market and started exporting to CIS countries.

The vast distribution network with demand for low cost medicines prompted the company to go for own manufacturing facilities. Thus, in the year 1994, a land of 210,000 square feet in the Industrial town of Bhiwadi in the state of Rajasthan was procured. In the year 1995, the company was enlisted in Bombay Stock Exchange.

In the year 2005, the company installed the second unit in the tax free zone at Haridwar in Uttarakhand, keeping the space with the ever increase in demand and fulfilling the commitment.

Read More